California State Teachers Retirement System (CalSTRS)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.7M Buy
156,724
+2,523
+2% +$1.72M 0.09% 190
2026
Q1
$119M Sell
154,201
-4,479
-3% -$3.43M 0.13% 139
2025
Q4
$122M Sell
158,680
-4,155
-3% -$2.82M 0.12% 135
2025
Q3
$91.6M Sell
162,835
-1,288
-0.8% -$728K 0.09% 186
2025
Q2
$86.2M Sell
164,123
-1,973
-1% -$1.1M 0.1% 185
2025
Q1
$105M Sell
166,096
-1,793
-1% -$1.23M 0.13% 146
2024
Q4
$120M Sell
167,889
-5,256
-3% -$4.41M 0.14% 128
2024
Q3
$182M Sell
173,145
-582
-0.3% -$648K 0.21% 85
2024
Q2
$183M Buy
173,727
+678
+0.4% +$657K 0.22% 80
2024
Q1
$167M Buy
173,049
+1,648
+1% +$1.57M 0.21% 94
2023
Q4
$151M Buy
171,401
+661
+0.4% +$544K 0.21% 96
2023
Q3
$141M Sell
170,740
-5,820
-3% -$4.57M 0.22% 89
2023
Q2
$127M Sell
176,560
-3,159
-2% -$2.44M 0.18% 104
2023
Q1
$148M Sell
179,719
-1,830
-1% -$1.38M 0.22% 91
2022
Q4
$131M Buy
181,549
+1,679
+0.9% +$1.24M 0.21% 99
2022
Q3
$124M Sell
179,870
-250
-0.1% -$157K 0.21% 90
2022
Q2
$106M Buy
180,120
+2,863
+2% +$1.86M 0.17% 115
2022
Q1
$124M Sell
177,257
-8,530
-5% -$5.4M 0.16% 114
2021
Q4
$117M Buy
185,787
+8,546
+5% +$5.25M 0.14% 132
2021
Q3
$107M Buy
177,241
+975
+0.6% +$605K 0.14% 129
2021
Q2
$98.5M Sell
176,266
-9,837
-5% -$4.98M 0.12% 144
2021
Q1
$88.1M Buy
186,103
+1,091
+0.6% +$531K 0.12% 150
2020
Q4
$89.4M Buy
185,012
+4,431
+2% +$2.39M 0.13% 139
2020
Q3
$101M Buy
180,581
+5,411
+3% +$3.28M 0.16% 111
2020
Q2
$109M Buy
175,170
+29,452
+20% +$16.7M 0.19% 98
2020
Q1
$71.2M Sell
145,718
-509
-0.3% -$210K 0.15% 126
2019
Q4
$54.9M Buy
146,227
+10,572
+8% +$3.56M 0.09% 194
2019
Q3
$37.6M Buy
135,655
+976
+0.7% +$289K 0.07% 253
2019
Q2
$42.2M Buy
134,679
+2,251
+2% +$749K 0.08% 223
2019
Q1
$54.4M Buy
132,428
+2,327
+2% +$958K 0.11% 178
2018
Q4
$48.6M Buy
130,101
+2,647
+2% +$969K 0.11% 173
2018
Q3
$51.5M Buy
127,454
+6
+0% +$2.28K 0.1% 189
2018
Q2
$44M Buy
127,448
+1,346
+1% +$421K 0.09% 203
2018
Q1
$43.4M Sell
126,102
-4,303
-3% -$1.5M 0.09% 208
2017
Q4
$49M Sell
130,405
-768
-0.6% -$311K 0.1% 193
2017
Q3
$58.6M Sell
131,173
-13,349
-9% -$6.35M 0.13% 159
2017
Q2
$71M Sell
144,522
-9,948
-6% -$4.35M 0.15% 134
2017
Q1
$59.9M Sell
154,470
-7,200
-4% -$2.67M 0.12% 169
2016
Q4
$59.3M Sell
161,670
-4,200
-3% -$1.6M 0.12% 168
2016
Q3
$66.7M Buy
165,870
+1,400
+0.9% +$562K 0.14% 144
2016
Q2
$57.4M Sell
164,470
-2,240
-1% -$863K 0.12% 158
2016
Q1
$60.1M Buy
166,710
+21,324
+15% +$8.79M 0.13% 153
2015
Q4
$78.9M Buy
145,386
+2,315
+2% +$1.25M 0.19% 102
2015
Q3
$66.5M Sell
143,071
-200
-0.1% -$107K 0.17% 114
2015
Q2
$73.1M Sell
143,271
-1,261
-0.9% -$615K 0.18% 110
2015
Q1
$65.3M Sell
144,532
-2,500
-2% -$1.06M 0.15% 127
2014
Q4
$60.3M Buy
147,032
+1,422
+1% +$559K 0.14% 143
2014
Q3
$52.5M Sell
145,610
-743
-0.5% -$249K 0.13% 153
2014
Q2
$41.3M Buy
146,353
+670
+0.5% +$199K 0.1% 190
2014
Q1
$43.7M Buy
145,683
+700
+0.5% +$216K 0.12% 176
2013
Q4
$39.9M Buy
144,983
+1,000
+0.7% +$288K 0.11% 184
2013
Q3
$45M Buy
143,983
+4,418
+3% +$1.16M 0.13% 143
2013
Q2
$31.4M Buy
+139,565
New +$32.5M 0.1% 196

Other funds holding REGN

California State Teachers Retirement System (CalSTRS)'s REGN Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Regeneron Pharmaceuticals (REGN) stake by 1.6% in Q2 2026, buying an estimated $1.72M and bringing the position to 156,724 shares worth $97.7M. The position accounts for 0.09% of the portfolio, ranked #190.

California State Teachers Retirement System (CalSTRS) first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $183M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 156,724 shares of Regeneron Pharmaceuticals worth $97.7M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 2,523 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.72M.
  • Regeneron Pharmaceuticals made up 0.09% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #190 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Regeneron Pharmaceuticals position peaked at $183M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.